{"id":"W2095357289","doi":"10.3109/10428190903370387","title":"State-of-the-art in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors: evolutionary trends in diagnosis, monitoring and treatment","year":2009,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Nilotinib; Dasatinib; Imatinib; Medicine; Chronic myelogenous leukemia; Myeloid leukemia; Tyrosine kinase; Tyrosine-kinase inhibitor; Disease; Imatinib mesylate; Intensive care medicine; Oncology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001018267,0.001449683,0.003149308,0.0007329314,0.0002441017,0.00005448484,0.001314798,0.0006805399,0.00001514993],"category_scores_gemma":[0.00005543444,0.0007631644,0.0009617164,0.003118085,0.0008290152,0.000185875,0.0004821905,0.0006458786,0.000004684761],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.05461212,"about_ca_system_score_gemma":0.008247184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00589669,"about_ca_topic_score_gemma":0.0009696279,"domain_scores_codex":[0.9924994,0.001041124,0.002715759,0.001257782,0.001342625,0.001143321],"domain_scores_gemma":[0.9951473,0.0008279535,0.001410849,0.002365399,0.00008653675,0.0001619401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0002054034,0.0008518731,0.006842528,0.005700338,0.0005124446,0.0005949644,0.00213469,0.0001432542,0.00001552617,0.0001036354,0.0004116182,0.9824837],"study_design_scores_gemma":[0.04673448,0.002597073,0.5824946,0.09897529,0.006014809,0.003100416,0.001529914,0.0005051004,0.0009693587,0.0002890865,0.2549261,0.00186374],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3677781,0.6285208,3.950591e-7,0.0001301372,0.0002724333,0.00267628,0.0001086031,0.00002014864,0.0004930568],"genre_scores_gemma":[0.2873456,0.7107818,0.00008632883,0.00007050535,0.0002154327,0.0009878393,0.0001116985,0.0000954713,0.0003052932],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.98062,"threshold_uncertainty_score":0.9998253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01962449380739391,"score_gpt":0.2794893266189277,"score_spread":0.2598648328115338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}